tirzepatide peptide science – 30mg – Prime Lab Peptides Simple Peptide tirzepatide: guide to
Description
Diabetologia 62:665675 Bergmann NC et al (2020) No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes
How the Study Was Conducted The trial was conducted at the Mental Health Centre Copenhagen in Denmark and lasted 26 weeks
GLP-1 stimulates insulin secretion, suppresses glucagon release, delays the emptying of the stomach, and increases satiety
A feeling of not being hungry, and/or a feeling of being full after just a small portion of food
It can lead to confusion, fainting, lightheadedness, and weakness
